Is it impossible to stop taking ivonib/Tosuvo once you start taking it?

The treatment strategy of Ivosidenib (Ivosidenib) is not "uninterruptible", but emphasizes the importance of continuous and regular administration to ensure that the drug maintains a stable effect in the body. As a metabolic targeted drug targeting IDH1 mutations, its efficacy takes a certain amount of time to have an impact at the cellular level, so treatment is usually ongoing rather than effective after short-term use.

What needs to be made clear is that whether to stop taking the drug depends on the patient's specific condition, efficacy, degree of adverse reactions, and physician evaluation, rather than the "non-stop feature" of the drug itself. After some patients reach a stable state, doctors may adjust the dose, extend the follow-up interval, or even consider discontinuation in individual cases based on response. Treatment is not a fixed model of "one stick to the end", but can be flexibly adjusted according to changes in the condition.

Many patients worry that"There will be an immediate rebound after stopping the medication." This understanding is not entirely accurate. Ivonib relies on continuous inhibition of mutant IDH1 enzyme activity. If treatment is interrupted, whether the condition changes depends on many factors, including mutation type, previous treatment, cell differentiation, and tumor progression rate. Therefore, discontinuation of medication needs to be done under the guidance of a doctor, rather than blindly stopping or continuing on your own.

In terms of long-term treatment, clinical practice generally adopts the management model of "continuous administration and monthly monitoring" to reduce adverse reactions, observe efficacy and protect patients' quality of life. For some patients who experience metabolic reactions or mild to moderate discomfort, they can improve by adjusting the dose, suspending and resuming, etc. This does not mean that "the drug cannot be stopped" or "the original dose must always be maintained."

In summary, the correct understanding of ivonib should be "continuous treatment rather than non-stop treatment". As long as it is evaluated on time under the guidance of a doctor and dynamically adjusted according to the condition, the treatment process is controllable and manageable.

Reference: https://www.tibsovo.com/